Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.092
Filtrar
Mais filtros

Intervalo de ano de publicação
1.
Nature ; 627(8004): 612-619, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38480877

RESUMO

Less than 30% of people in Africa received a dose of the COVID-19 vaccine even 18 months after vaccine development1. Here, motivated by the observation that residents of remote, rural areas of Sierra Leone faced severe access difficulties2, we conducted an intervention with last-mile delivery of doses and health professionals to the most inaccessible areas, along with community mobilization. A cluster randomized controlled trial in 150 communities showed that this intervention with mobile vaccination teams increased the immunization rate by about 26 percentage points within 48-72 h. Moreover, auxiliary populations visited our community vaccination points, which more than doubled the number of inoculations administered. The additional people vaccinated per intervention site translated to an implementation cost of US $33 per person vaccinated. Transportation to reach remote villages accounted for a large share of total intervention costs. Therefore, bundling multiple maternal and child health interventions in the same visit would further reduce costs per person treated. Current research on vaccine delivery maintains a large focus on individual behavioural issues such as hesitancy. Our study demonstrates that prioritizing mobile services to overcome access difficulties faced by remote populations in developing countries can generate increased returns in terms of uptake of health services3.


Assuntos
Vacinas contra COVID-19 , Serviços de Saúde Comunitária , Vacinação em Massa , Unidades Móveis de Saúde , Serviços de Saúde Rural , Cobertura Vacinal , Criança , Humanos , Serviços de Saúde Comunitária/métodos , Serviços de Saúde Comunitária/organização & administração , COVID-19/prevenção & controle , Vacinas contra COVID-19/administração & dosagem , Vacinas contra COVID-19/economia , Vacinas contra COVID-19/provisão & distribuição , Unidades Móveis de Saúde/organização & administração , Serviços de Saúde Rural/organização & administração , Serra Leoa , Meios de Transporte/economia , Cobertura Vacinal/economia , Cobertura Vacinal/métodos , Cobertura Vacinal/estatística & dados numéricos , Hesitação Vacinal , Vacinação em Massa/métodos , Vacinação em Massa/organização & administração , Feminino , Adulto , Mães
2.
Front Public Health ; 11: 1271162, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37915810

RESUMO

The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated phased rollout plans that changed frequently as availability of the vaccine waxed and waned. The COVID-19 pandemic also disproportionately affected communities of color and communities with barriers to accessing healthcare. In the setting of these difficulties, a program was created specifically to address inequity in vaccine administration with a focus on communities of color and linguistic diversity as well as those who had technological barriers to online sign-up processes common at mass vaccination sites. This effort, the Mobile Vaccine Equity Enhancement Program (MVeeP), delivered over 12,000 vaccines in 24 months through a reproducible set of practices that can inform equity-driven vaccine efforts in future pandemics.


Assuntos
COVID-19 , Vacinas , Humanos , Pandemias , Vacinação em Massa , Vacinação , COVID-19/prevenção & controle
3.
Hum Vaccin Immunother ; 19(3): 2276619, 2023 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-38013426

RESUMO

Acute gastroenteritis (AGE) caused by rotavirus (RV) remains a public health issue in China. To accelerate the mass rotavirus vaccination, it is important to inform the policy maker, and the public of the economic burden caused by rotavirus infection. A meta-analysis was conducted applying standardized algorithms. Articles published before January 1, 2023, in English and Chinese were searched through PubMed, CNKI, and WanFang Data. Studies with cost analysis of RV AGE were included. A random-effects model was applied to synthesize the total cost of RV AGE from the societal perspective. A prospective survey aimed to measure the cost of RV AGE was conducted in 2021 and 2022 in Shaoxing city, Zhejiang province, that can represent the developed region. The cost data was applied as deviation indicator, in comparison with the pooled estimate generated from meta-analysis. Totally 286 articles were identified, and eventually 12 studies were included. The pooled total social cost of RV AGE was US$282.1 (95%CI: US$213.4-350.7). The pooled private cost of RV AGE was US$206.4 (95%CI: US$155.2-257.5). RV AGE hospitalized and RV AGE incurred in developed regions caused remarkable higher burden (US$631.2 [95%CI: US$512.6-749.8], and US$333.6 [95%CI: US$234.1-433.2] respectively), compared to RV AGE treated at outpatient, and incurred in less developed regions. Our study demonstrates that RV AGE causes a significant economic burden in China. Given the promising effectiveness and highly cost-effective, introduction of rotavirus vaccines in national immunization programs could substantially reduce the economic burden in China.


Assuntos
Gastroenterite , Infecções por Rotavirus , Vacinas contra Rotavirus , Humanos , Lactente , Análise Custo-Benefício , População do Leste Asiático , Gastroenterite/epidemiologia , Gastroenterite/prevenção & controle , Gastroenterite/virologia , Vacinação em Massa , Estudos Prospectivos , Rotavirus , Infecções por Rotavirus/epidemiologia , Infecções por Rotavirus/prevenção & controle , Pré-Escolar
4.
Nat Commun ; 14(1): 5370, 2023 09 07.
Artigo em Inglês | MEDLINE | ID: mdl-37679314

RESUMO

Previous research suggests that dog mass vaccination campaigns can eliminate rabies locally, resulting in large human and animal life gains. Despite these demonstrated benefits, dog vaccination programs remain scarce on the African continent. We conducted a benefit-cost analysis to demonstrate that engaging into vaccination campaigns is the dominant strategy for most countries even in the absence of coordinated action between them. And quantify how coordinated policy measures across countries in Africa could impact rabies incidence and associated costs. We show that coordinated dog mass vaccination between countries and PEP would lead to the elimination of dog rabies in Africa with total welfare gains of USD 9.5 billion (95% CI: 8.1 - 11.4 billion) between 2024 and 2054 (30 years). Coordinated disease control between African countries can lead to more socially and ecologically equitable outcomes by reducing the number of lost human lives to almost zero and possibly eliminating rabies.


Assuntos
Doenças do Cão , Vacinação em Massa , Vacina Antirrábica , Raiva , Animais , Cães , Humanos , África/epidemiologia , População Negra , Análise Custo-Benefício , Vacinação em Massa/métodos , Raiva/epidemiologia , Raiva/prevenção & controle , Doenças do Cão/epidemiologia , Doenças do Cão/prevenção & controle , Vacina Antirrábica/uso terapêutico
5.
J Health Organ Manag ; ahead-of-print(ahead-of-print)2023 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-37537717

RESUMO

PURPOSE: Scientific description of the organization and management of a temporary large scale healthcare (T-LSHc) vaccination clinic and evidence-based guidance for future temporary healthcare (T-Hc) services. DESIGN/METHODOLOGY/APPROACH: Mixed-methods rapid feedback case study, using interviews, document analysis and quantitative data, with both data collection and analysis guided by a research-informed systems program theory of the clinic. FINDINGS: Private contractors were not willing to bid for contracts to set up and close a T-LSHc vaccination clinic in 2022, although they had done so earlier in the year. The public health system was able successfully to set up and run the clinic itself for 2 months, serving 3,000 people a day at its peak. Part of the success was because a dedicated unit to set up and run T-Hc services had been created in 2020. The Stockholm organization model differed from the Milan model by using information technology to reduce the need for a large number of on-site doctors. RESEARCH LIMITATIONS/IMPLICATIONS: There may be recall bias in interview data as interviews were carried out four months after the closing of the clinic. The conclusions apply to clinically simple but managerially complex T-Hc services but are limited to public healthcare systems operating in a similar context to that of the case study service. The study contributes to the new science of healthcare crisis organization and management and fills gaps in knowledge in disaster medicine for enduring and fluctuating health crises. The findings show the importance of a capacity to establish and manage T-Hc, and of the specialist management and HIT competence that health systems will need to build to meet the crises that threaten our health, both now and in the future. PRACTICAL IMPLICATIONS: Public healthcare systems can provide clinically simple and managerially complex T-Hc services quickly and successfully if they have experience and capacity to plan and set up such services, skilled operational managers respected by staff, staff who can be redeployed, and suitable health information technology. SOCIAL IMPLICATIONS: The need for healthcare services to respond to crises is likely to increase in the future. Information for creating the service may be limited at first and changing. The exact nature of the health threat may be uncertain, as may the demand and needs of subpopulations and individuals. The study findings can help to respond quickly to reduce morbidity illness and death through creating and organizing temporary large-scale public healthcare services when existing services cannot be reorganized to meet the scale of the need. ORIGINALITY/VALUE: This article is the first detailed empirical description and analysis of a large-scale temporary healthcare service operated by the primary care division of an integrated public healthcare system, with research informed guidance for future services of this type in similar contexts. This article compares two organization models of T-LSHc services, and contributes to an emerging subdiscipline of the organization and management of disaster and crisis healthcare.


Assuntos
Atenção à Saúde , Vacinação em Massa , Humanos , Serviços de Saúde
6.
BMJ Glob Health ; 8(5)2023 05.
Artigo em Inglês | MEDLINE | ID: mdl-37257938

RESUMO

INTRODUCTION: Given the ageing epidemic of tuberculosis (TB), China is facing an unprecedented opportunity provided by the first clinically approved next-generation TB vaccine Vaccae, which demonstrated 54.7% efficacy for preventing reactivation from latent infection in a phase III trial. We aim to assess the population-level health and economic impacts of introducing Vaccae vaccination to inform policy-makers. METHODS: We evaluated a potential national Vaccae vaccination programme in China initiated in 2024, assuming 20 years of protection, 90% coverage and US$30/dose government contract price. An age-structured compartmental model was adapted to simulate three strategies: (1) no Vaccae; (2) mass vaccination among people aged 15-74 years and (3) targeted vaccination among older adults (60 years). Cost analyses were conducted from the healthcare sector perspective, discounted at 3%. RESULTS: Considering postinfection efficacy, targeted vaccination modestly reduced TB burden (~20%), preventing cumulative 8.01 (95% CI 5.82 to 11.8) million TB cases and 0.20 (0.17 to 0.26) million deaths over 2024-2050, at incremental cost-effectiveness ratio of US$4387 (2218 to 10 085) per disability adjusted life year averted. The implementation would require a total budget of US$22.5 (17.6 to 43.4) billion. In contrast, mass vaccination had a larger bigger impact on the TB epidemic, but the overall costs remained high. Although both preinfection and postinfection vaccine efficacy type might have a maximum impact (>40% incidence rate reduction in 2050), it is important that the vaccine price does not exceed US$5/dose. CONCLUSION: Vaccae represents a robust and cost-effective choice for TB epidemic control in China. This study may facilitate the practice of evidence-based strategy plans for TB vaccination and reimbursement decision making.


Assuntos
Tuberculose , Vacinas , Humanos , Idoso , Análise Custo-Benefício , Vacinação , Vacinação em Massa , Tuberculose/prevenção & controle , China
7.
Psicol. ciênc. prof ; 43: e241608, 2023. tab, graf
Artigo em Português | LILACS, INDEXPSI | ID: biblio-1448958

RESUMO

O distanciamento social ocasionado pela pandemia de Covid-19 levou a profundas mudanças na rotina das famílias com crianças pequenas, aumentando o estresse no ambiente doméstico. Este estudo analisou a experiência de planejamento e implementação de um projeto de extensão universitária que ofereceu orientação a pais com filhos de 0 a 11 anos por meio de chamadas de áudio durante a pandemia. O protocolo de atendimento foi desenvolvido para atender às necessidades de famílias de baixa renda e listava problemas específicos relacionados ao confinamento em casa e ao fechamento das escolas seguidos por uma variedade de estratégias de enfrentamento. A análise de 223 queixas relatadas pelos usuários em 130 ligações revelou que 94% dos problemas referidos pelos pais foram contemplados pelo protocolo de atendimento e estavam relacionados aos problemas externalizantes (39%) ou internalizantes (26%) das crianças ou ao declínio do bem-estar subjetivo dos pais (29%). Serviços de apoio devem orientar os pais quanto ao uso de práticas responsivas e assertivas que promovam o bem-estar emocional da criança e estabeleçam expectativas comportamentais em contextos estressantes. A diminuição dos conflitos entre pais e filhos resultante do uso dessas estratégias tende a reduzir o sofrimento dos pais, aumentando sua sensação de bem-estar subjetivo. Recomenda-se ampla divulgação dessas iniciativas e seguimento dos casos.(AU)


The social distancing the COVID-19 pandemic entailed has led to profound changes in the routine of families with young children, increasing stress in the home environment. This study analyzed the experience of planning and implementing a university extension program that offered support to parents with children from 0 to 11 years old via audio calls during the COVID-19 pandemic. The service protocol was developed to meet the needs of low-income families and listed specific problems related to home confinement and school closure followed by a variety of coping strategies. The analysis of 223 complaints reported by users in 130 calls revealed that 94% of the problems reported by parents were addressed by the protocol and were related to children's externalizing (39%) or internalizing (26%) problems or to the decline in parents' subjective well-being (29%). Support services should guide parents on the use of responsive and assertive practices that promote the child's emotional well-being and set behavioral expectations in stressful contexts. The reduction in conflicts between parents and children resulting from the use of these strategies tends to reduce parents' suffering, increasing their sense of subjective well-being. Wide dissemination of these initiatives and case follow-up are recommended.(AU)


La distancia social causada por la pandemia de COVID-19 condujo a cambios profundos en la rutina de las familias con niños pequeños, aumentando el estrés en el entorno del hogar. Este estudio analizó la experiencia de planificar e implementar un proyecto de extensión universitaria que ofreció orientación a los padres con niños de cero a 11 años a través de llamadas de audio durante la pandemia COVID-19. El protocolo de atención se desarrolló para satisfacer las necesidades de las familias de bajos ingresos y enumeró problemas específicos relacionados con el confinamiento en el hogar y el cierre de la escuela, seguido de una variedad de estrategias de afrontamiento. El análisis de 223 quejas informadas por los usuarios en 130 llamadas reveló que el 94% de los problemas informados por los padres fueron abordados por el protocolo de atención y estaban relacionados con los problemas de externalización (39%) o internalización (26%) de los niños o la disminución del bienestar subjetivo de los padres (29%). Los servicios de apoyo deberían aconsejar a los padres sobre el uso de prácticas receptivas y asertivas que promuevan el bienestar emocional del niño y establezcan expectativas de comportamiento en contextos estresantes. La reducción de los conflictos entre padres e hijos como resultado del uso de estas estrategias tiende a reducir el sufrimiento de los padres, aumentando su sensación de bienestar subjetivo. Se recomienda una amplia difusión de estas iniciativas y seguimiento de casos.(AU)


Assuntos
Humanos , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Orientação , Pais , Satisfação Pessoal , Criança , Comportamento Problema , COVID-19 , Ansiedade , Relações Pais-Filho , Apetite , Jogos e Brinquedos , Resolução de Problemas , Psicologia , Agitação Psicomotora , Qualidade de Vida , Leitura , Recreação , Ensino de Recuperação , Infecções Respiratórias , Segurança , Salários e Benefícios , Serviços de Saúde Escolar , Autoimagem , Transtorno Autístico , Sono , Ajustamento Social , Condições Sociais , Conformidade Social , Meio Social , Isolamento Social , Problemas Sociais , Socialização , Fatores Socioeconômicos , Análise e Desempenho de Tarefas , Telefone , Temperamento , Terapêutica , Tempo , Desemprego , Violência , Terapia Comportamental , Jornada de Trabalho , Políticas, Planejamento e Administração em Saúde , Abuso Sexual na Infância , Tédio , Neurociências , Viroses , Atividades Cotidianas , Luto , Exercício Físico , Divórcio , Maus-Tratos Infantis , Desenvolvimento Infantil , Saúde Mental , Vacinação em Massa , Terapia de Relaxamento , Imunização , Comportamento Autodestrutivo , Direitos Civis , Poder Familiar , Transtorno de Pânico , Entrevista , Cognição , Violência Doméstica , Transmissão de Doença Infecciosa , Aula , Crianças com Deficiência , Senso de Humor e Humor , Internet , Criatividade , Intervenção na Crise , Choro , Vulnerabilidade a Desastres , Impacto Psicossocial , Autonomia Pessoal , Morte , Amigos , Agressão , Depressão , Impulso (Psicologia) , Economia , Educação Especial , Escolaridade , Emoções , Empatia , Docentes , Conflito Familiar , Relações Familiares , Medo , Consumo Excessivo de Bebidas Alcoólicas , Refeições , Retorno ao Trabalho , Esperança , Otimismo , Pessimismo , Autocontrole , Fobia Social , Sistemas de Apoio Psicossocial , Equilíbrio Trabalho-Vida , Experiências Adversas da Infância , Tempo de Tela , Asco , Tristeza , Solidariedade , Angústia Psicológica , Intervenção Psicossocial , Teletrabalho , Estresse Financeiro , Insegurança Alimentar , Análise de Sentimentos , Fatores Sociodemográficos , Vulnerabilidade Social , Apoio Familiar , Governo , Culpa , Saúde Holística , Homeostase , Hospitalização , Trabalho Doméstico , Distúrbios do Início e da Manutenção do Sono , Ira , Aprendizagem , Deficiências da Aprendizagem , Atividades de Lazer , Solidão , Transtornos Mentais
8.
Science ; 378(6625): 1158-1159, 2022 12 16.
Artigo em Inglês | MEDLINE | ID: mdl-36520904

RESUMO

COVAX distributed 1.84 billion vaccine doses, but many came too late. Can the world do better next time?


Assuntos
Vacinas contra COVID-19 , COVID-19 , Saúde Global , Equidade em Saúde , Vacinação em Massa , Pandemias , Humanos , Pandemias/prevenção & controle , COVID-19/prevenção & controle , Vacinas contra COVID-19/uso terapêutico
9.
Artigo em Alemão | MEDLINE | ID: mdl-36434393

RESUMO

The main task of the Association of Statutory Health Insurance Physicians Westfalen-Lippe (KVWL) is to provide comprehensive outpatient medical and psychotherapeutic care in the region of Westfalen-Lippe (WL). It represents approximately 15,000 physicians and psychotherapists. Since the beginning of the COVID-19 pandemic, the range of tasks has expanded to include dealing with the pandemic and its containment.This article describes the implementation of the COVID-19 vaccination campaign in WL, the northeastern part of North Rhine-Westphalia (NRW) with a population of 8.3 million, as well as the experience gained in setting up vaccination centers and conducting mass vaccinations. A key problem throughout the time of mass vaccination was the unsteady availability of vaccines. This negatively impacted the operation of the vaccination centers, particularly their utilization and performance. Another burden in the implementation of the vaccination targets was the frequent lack of transparency and comprehensible communication in the dedicated guidelines for the vaccination order (prioritization). Nevertheless, the policy targets were entirely implemented.


Assuntos
COVID-19 , Médicos , Humanos , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Pandemias/prevenção & controle , Alemanha/epidemiologia , Vacinação , Vacinação em Massa , Seguro Saúde
10.
12.
RECIIS (Online) ; 16(2): 221-226, abr.-jun. 2022. graf
Artigo em Português | LILACS | ID: biblio-1378340

RESUMO

A dinâmica da pandemia de covid-19 vem evoluindo segundo fases marcadas por uma maior ou menor taxa de infecção, e diferentes impactos sobre o sistema de saúde e a mortalidade. Essas fases foram estudadas segundo quatro indicadores disponibilizados no sistema MonitoraCovid-19: positividade de testes de diagnóstico, número de casos, número de óbitos e o número de pessoas com ao menos duas doses de vacinas ­ padronizados numa série histórica para permitir sua comparação. São distinguidas cinco fases, marcadas pela circulação de diferentes variantes do vírus, estratégias de implementação ­ ou mesmo boicote ­ de medidas de controle e a vacinação gradativa da população. Esses indicadores podem ser usados no futuro para monitorar tendências e apontar políticas públicas adequadas.


The dynamics of the covid-19 pandemic has evolved according to phases marked by a higher or lower rate of infection, the different impacts on the health system and mortality. These phases were studied according to four indicators made available by the MonitoraCovid-19 system: positivity rates of diagnostic tests, number of cases, number of deaths and number of people who received at least two vaccine doses, standardized in a historical series to allow their comparison. Five phases are discerned, evidenced by the circulation of different virus variants, strategies employed to implement -or even undermine ­ disease control measures and the gradual vaccination of the population. These indicators can be used in the future to monitor trends and point out appropriate public policies.


La dinámica de la pandemia de covid-19 ha evolucionado según fases marcadas por una mayor o menor tasa de contagios, sus diferentes impactos en el sistema de salud y mortalidad. Estas fases se estudiaron según cuatro indicadores disponibles en el sistema MonitoraCovid-19: positividad de las pruebas diagnósticas, número de casos, número de defunciones y el número de personas vacunadas con al menos dos dosis, estandarizados en una serie histórica para permitir su comparación. Se distinguen cuatro fases, marcadas por la circulación de diferentes variantes del virus, las estrategias de implementación - o mismo el boicoteode medidas de control y la paulatina vacunación de la población. Estos indicadores pueden utilizarse en el futuro para monitorear tendencias y señalar políticas públicas apropiadas.


Assuntos
Humanos , Pandemias , COVID-19 , Política de Saúde , Indicadores e Reagentes , Brasil , Vacinação em Massa , Mortalidade , Técnicas e Procedimentos Diagnósticos
13.
Artigo em Inglês | MEDLINE | ID: mdl-35329322

RESUMO

BACKGROUND: The COVID-19 mass vaccination campaign posed new challenges not only from a healthcare perspective, but also in terms of distribution, logistics, and organization. Managing clinical risk in off-site vaccination centers during a pandemic provided a new opportunity for the training and acquisition of competencies through continuous learning from adverse events. The aim of this report, based on a review of activity, was to identify the most recurrent and high-risk failures of the vaccination process in a mass vaccination center. METHODS: Adverse events and near misses reported during the first 11 months of activity (February 2021-January 2022) in the mass vaccination center of Verona (Italy) were evaluated. RESULTS: From 15 February 2021 to 17 January 2022 the center administered about 460,000 doses to the population and nine adverse events and one near miss were reported. Most of the events were errors in vaccine administration, either in principle, dosage, or timing with respect to the indicated schedule. All events had minor outcomes. Communication errors, inadequate training, and general organizational issues were the most recurrent factors contributing to the events. CONCLUSIONS: Risk mitigation during mass vaccination in temporary sites is an essential element of a successful vaccination campaign. The reporting of adverse events should be encouraged in order to obtain as much information as possible for a continuous improvement of the activity.


Assuntos
Vacinas contra COVID-19 , COVID-19 , COVID-19/prevenção & controle , Vacinas contra COVID-19/efeitos adversos , Humanos , Vacinação em Massa , Gestão de Riscos , Vacinação
14.
Front Public Health ; 10: 769898, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35356016

RESUMO

Background: In Africa, rabies causes an estimated 24,000 human deaths annually. Mass dog vaccinations coupled with timely post-exposure prophylaxis (PEP) for dog-bite patients are the main interventions to eliminate human rabies deaths. A well-informed healthcare workforce and the availability and accessibility of rabies biologicals at health facilities are critical in reducing rabies deaths. We assessed awareness and knowledge regarding rabies and the management of rabies among healthcare workers, and PEP availability in rural eastern Kenya. Methodology: We interviewed 73 healthcare workers from 42 healthcare units in 13 wards in Makueni and Kibwezi West sub-counties, Makueni County, Kenya in November 2018. Data on demographics, years of work experience, knowledge of rabies, management of bite and rabies patients, and availability of rabies biologicals were collected and analyzed. Results: Rabies PEP vaccines were available in only 5 (12%) of 42 health facilities. None of the health facilities had rabies immunoglobulins in stock at the time of the study. PEP was primarily administered intramuscularly, with only 11% (n = 8) of the healthcare workers and 17% (7/42) healthcare facilities aware of the dose-sparing intradermal route. Less than a quarter of the healthcare workers were aware of the World Health Organization categorization of bite wounds that guides the use of PEP. Eighteen percent (n = 13) of healthcare workers reported they would administer PEP for category I exposures even though PEP is not recommended for this category of exposure. Only one of six respondents with acute encephalitis consultation considered rabies as a differential diagnosis highlighting the low index of suspicion for rabies. Conclusion: The availability and use of PEP for rabies was sub-optimal. We identified two urgent needs to support rabies elimination programmes: improving availability and access to PEP; and targeted training of the healthcare workers to improve awareness on bite wound management, judicious use of PEP including appropriate risk assessment following bites and the use of the dose-sparing intradermal route in facilities seeing multiple bite patients. Global and domestic funding plan that address these gaps in the human health sector is needed for efficient rabies elimination in Africa.


Assuntos
Erradicação de Doenças , Necessidades e Demandas de Serviços de Saúde , Raiva , Saúde da População Rural , Animais , Mordeduras e Picadas/terapia , Erradicação de Doenças/métodos , Erradicação de Doenças/organização & administração , Doenças do Cão/prevenção & controle , Doenças do Cão/virologia , Cães , Conhecimentos, Atitudes e Prática em Saúde , Pessoal de Saúde/psicologia , Humanos , Quênia/epidemiologia , Vacinação em Massa/veterinária , Profilaxia Pós-Exposição/provisão & distribuição , Raiva/epidemiologia , Raiva/prevenção & controle , Raiva/veterinária , Vacina Antirrábica/provisão & distribuição
16.
Vaccine ; 40(9): 1306-1315, 2022 02 23.
Artigo em Inglês | MEDLINE | ID: mdl-35109968

RESUMO

INTRODUCTION: Despite seasonal influenza vaccination programmes in most countries targeting individuals aged ≥ 65 (or ≥ 55) years and high risk-groups, significant disease burden remains. We explored the impact and cost-effectiveness of 27 vaccination programmes targeting the elderly and/or children in eight European settings (n = 205.8 million). METHODS: We used an age-structured dynamic-transmission model to infer age- and (sub-)type-specific seasonal influenza virus infections calibrated to England, France, Ireland, Navarra, The Netherlands, Portugal, Scotland, and Spain between 2010/11 and 2017/18. The base-case vaccination scenario consisted of non-adjuvanted, non-high dose trivalent vaccines (TV) and no universal paediatric vaccination. We explored i) moving the elderly to "improved" (i.e., adjuvanted or high-dose) trivalent vaccines (iTV) or non-adjuvanted non-high-dose quadrivalent vaccines (QV); ii) adopting mass paediatric vaccination with TV or QV; and iii) combining the elderly and paediatric strategies. We estimated setting-specific costs and quality-adjusted life years (QALYs) gained from the healthcare perspective, and discounted QALYs at 3.0%. RESULTS: In the elderly, the estimated numbers of infection per 100,000 population are reduced by a median of 261.5 (range across settings: 154.4, 475.7) when moving the elderly to iTV and by 150.8 (77.6, 262.3) when moving them to QV. Through indirect protection, adopting mass paediatric programmes with 25% uptake achieves similar reductions in the elderly of 233.6 using TV (range: 58.9, 425.6) or 266.5 using QV (65.7, 477.9), with substantial health gains from averted infections across ages. At €35,000/QALY gained, moving the elderly to iTV plus adopting mass paediatric QV programmes provides the highest mean net benefits and probabilities of being cost-effective in all settings and paediatric coverage levels. CONCLUSION: Given the direct and indirect protection, and depending on the vaccine prices, model results support a combination of having moved the elderly to an improved vaccine and adopting universal paediatric vaccination programmes across the European settings.


Assuntos
Vacinas contra Influenza , Influenza Humana , Idoso , Criança , Análise Custo-Benefício , Humanos , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Vacinação em Massa , Pessoa de Meia-Idade , Anos de Vida Ajustados por Qualidade de Vida , Estações do Ano , Vacinação
17.
PLoS Comput Biol ; 18(2): e1009872, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-35213541

RESUMO

COVID-19 vaccines have been approved for children of age five and older in many countries. However, there is an ongoing debate as to whether children should be vaccinated and at what priority. In this work, we use mathematical modeling and optimization to study how vaccine allocations to different age groups effect epidemic outcomes. In particular, we consider the effect of extending vaccination campaigns to include the vaccination of children. When vaccine availability is limited, we consider Pareto-optimal allocations with respect to competing measures of the number of infections and mortality and systematically study the trade-offs among them. In the scenarios considered, when some weight is given to the number of infections, we find that it is optimal to allocate vaccines to adolescents in the age group 10-19, even when they are assumed to be less susceptible than adults. We further find that age group 0-9 is included in the optimal allocation for sufficiently high values of the basic reproduction number.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Alocação de Recursos para a Atenção à Saúde/estatística & dados numéricos , Vacinação em Massa , Modelos Estatísticos , Adolescente , Adulto , COVID-19/epidemiologia , COVID-19/prevenção & controle , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Vacinação em Massa/métodos , Vacinação em Massa/estatística & dados numéricos , Adulto Jovem
19.
Arch Dis Child ; 107(3): e1, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-34732388

RESUMO

Whether all children under 12 years of age should be vaccinated against COVID-19 remains an ongoing debate. The relatively low risk posed by acute COVID-19 in children, and uncertainty about the relative harms from vaccination and disease mean that the balance of risk and benefit of vaccination in this age group is more complex. One of the key arguments for vaccinating healthy children is to protect them from long-term consequences. Other considerations include population-level factors, such as reducing community transmission, vaccine supply, cost, and the avoidance of quarantine, school closures and other lockdown measures. The emergence of new variants of concern necessitates continual re-evaluation of the risks and benefits. In this review, we do not argue for or against vaccinating children against COVID-19 but rather outline the points to consider and highlight the complexity of policy decisions on COVID-19 vaccination in this age group.


Assuntos
Vacinas contra COVID-19 , COVID-19/prevenção & controle , Vacinação em Massa , Fatores Etários , COVID-19/complicações , COVID-19/transmissão , Vacinas contra COVID-19/efeitos adversos , Vacinas contra COVID-19/economia , Vacinas contra COVID-19/provisão & distribuição , Criança , Custos de Medicamentos , Humanos , Pandemias/prevenção & controle , Medição de Risco , SARS-CoV-2
20.
PLoS Comput Biol ; 17(12): e1009697, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34898617

RESUMO

For the control of COVID-19, vaccination programmes provide a long-term solution. The amount of available vaccines is often limited, and thus it is crucial to determine the allocation strategy. While mathematical modelling approaches have been used to find an optimal distribution of vaccines, there is an excessively large number of possible allocation schemes to be simulated. Here, we propose an algorithm to find a near-optimal allocation scheme given an intervention objective such as minimization of new infections, hospitalizations, or deaths, where multiple vaccines are available. The proposed principle for allocating vaccines is to target subgroups with the largest reduction in the outcome of interest. We use an approximation method to reconstruct the age-specific transmission intensity (the next generation matrix), and express the expected impact of vaccinating each subgroup in terms of the observed incidence of infection and force of infection. The proposed approach is firstly evaluated with a simulated epidemic and then applied to the epidemiological data on COVID-19 in the Netherlands. Our results reveal how the optimal allocation depends on the objective of infection control. In the case of COVID-19, if we wish to minimize deaths, the optimal allocation strategy is not efficient for minimizing other outcomes, such as infections. In simulated epidemics, an allocation strategy optimized for an outcome outperforms other strategies such as the allocation from young to old, from old to young, and at random. Our simulations clarify that the current policy in the Netherlands (i.e., allocation from old to young) was concordant with the allocation scheme that minimizes deaths. The proposed method provides an optimal allocation scheme, given routine surveillance data that reflect ongoing transmissions. This approach to allocation is useful for providing plausible simulation scenarios for complex models, which give a more robust basis to determine intervention strategies.


Assuntos
Algoritmos , Vacinas contra COVID-19/uso terapêutico , COVID-19/prevenção & controle , SARS-CoV-2 , Vacinação/métodos , Fatores Etários , COVID-19/epidemiologia , COVID-19/imunologia , Vacinas contra COVID-19/provisão & distribuição , Biologia Computacional , Simulação por Computador , Alocação de Recursos para a Atenção à Saúde/métodos , Alocação de Recursos para a Atenção à Saúde/estatística & dados numéricos , Humanos , Vacinação em Massa/métodos , Vacinação em Massa/estatística & dados numéricos , Países Baixos/epidemiologia , Pandemias/prevenção & controle , Pandemias/estatística & dados numéricos , SARS-CoV-2/imunologia , Vacinação/estatística & dados numéricos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA